Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Urologists believe PSA test remains a valued tool to detect prostate cancer early.

Austenfeld M, Albani J, Albani F.

Mo Med. 2013 May-Jun;110(3):191. No abstract available.

PMID:
23829098
2.

[Urologists introduce a new round of prostate specific antigen discussion].

[No authors listed]

Aktuelle Urol. 2013 Jul;44(4):257-8. doi: 10.1055/s-0033-1351764. German. No abstract available.

PMID:
23904120
3.
4.
5.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.

PMID:
9674714
6.

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.

McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ Jr.

Urology. 2002 Oct;60(4):628-33.

PMID:
12385923
7.

PSA screening: the USPSTF got it wrong.

Scherger JE.

J Fam Pract. 2013 Nov;62(11):616, 618. No abstract available.

8.

Screening for prostate cancer: a comparison of urologists and primary care physicians.

McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC.

South Med J. 1996 Sep;89(9):885-8.

PMID:
8790311
9.
10.

The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, Stahl CA.

J Urol. 1994 Jan;151(1):88-93. Erratum in: J Urol 1994 Aug;152(2 Pt 1):495.

PMID:
7504748
11.

Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.

Jønler M, Eddy B, Poulsen J.

Scand J Urol Nephrol. 2005;39(3):214-8.

PMID:
16118092
12.

Re: Current trends in prostate cancer diagnosis and staging among United States urologists.

Huncharek M, Muscat J.

J Urol. 1998 Aug;160(2):506. No abstract available.

PMID:
9679916
13.
14.

PSA and the family physician.

Barkin J.

Can J Urol. 2011 Apr;18 Suppl:20-3. Review.

PMID:
21501547
15.

Prostate-specific antigen and the early diagnosis of prostate cancer.

Caplan A, Kratz A.

Am J Clin Pathol. 2002 Jun;117 Suppl:S104-8. Review.

PMID:
14569806
16.

Practice patterns of Korean urologists for screening and managing prostate cancer according to PSA level.

Chung MS, Lee SH, Lee DH, Kim SJ, Kim CS, Lee KS, Jung JI, Kim SW, Lee YS, Chung BH.

Yonsei Med J. 2012 Nov 1;53(6):1136-41. doi: 10.3349/ymj.2012.53.6.1136.

17.

The effect of lowering the prostate-specific antigen normal cutoff on referral rates to urology.

Shenker BS, Stern J.

J Am Board Fam Med. 2012 Nov-Dec;25(6):927-9. doi: 10.3122/jabfm.2012.06.120172.

18.

Harms of PSA screening outweigh benefits for most men, says American College of Physicians.

McCarthy M.

BMJ. 2013 Apr 9;346:f2232. doi: 10.1136/bmj.f2232. No abstract available.

PMID:
23571746
19.

Prostate-specific antigen as a screening test for prostate cancer. The United States experience.

Arcangeli CG, Ornstein DK, Keetch DW, Andriole GL.

Urol Clin North Am. 1997 May;24(2):299-306. Review.

PMID:
9126227
20.

[Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].

Norderhaug IN, Wisløff T, Fosså S, Sandberg S, Malde K, Forland F, Førde OH.

Tidsskr Nor Laegeforen. 2004 Nov 18;124(22):2893-5. Norwegian.

Supplemental Content

Support Center